Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -5 of 5 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 11/26/2007


1.		Phase III Randomized Study of Clodronate for Locally Advanced Adenocarcinoma of the Prostate

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				over 18								MRC-PR04 EU-94032

Last Modified: 3/8/2005


2.		Phase III Randomized Double-Blind Study of Clodronate vs Placebo in Patients with Prostate Cancer Metastatic to Bone Who Are Commencing or Responding to Initial Hormone Therapy (Summary Last Modified 03/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				any age								MRC-PR05 EU-94033

Last Modified: 6/20/2008 First Published: 4/1/1998


3.		Phase III Randomized Study of Mitoxantrone and Prednisone With or Without Clodronate in Patients with Hormone Refractory Metastatic Prostate Cancer and Pain

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				Any age								CAN-NCIC-PR6 NCT00003232, PR6

Last Modified: 4/11/2005 First Published: 2/1/2001


4.		Phase III Randomized Study of Adjuvant Clodronate With or Without Systemic Chemotherapy and/or Hormonal Therapy in Women With Early Stage Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				Not specified				NCI				NSABP-B-34 SWOG-NSABP-B-34, NCCTG-NSABP-B-34, NCT00009945

Last Modified: 7/1/1994


5.		Phase III Randomized Study of Clodronate vs Placebo during Initial Therapy with DOX/BCNU/CTX/L-PAM (ABCM) in Patients with Previously Untreated Multiple Myeloma and of IFN-A Maintenance Therapy vs No Maintenance During First Plateau

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care, Treatment				Closed				under 75								MRC-LEUK-MYEL-INF EU-92025

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute